Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
BioMed Research International
/
2009
/
Article
/
Fig 4
/
Research Article
OXavidin for Tissue Targeting Biotinylated Therapeutics
Figure 4
Immunohistochemistry of avidin (a,c) or OXavidin (b,d) injected normal muscle (a,b) or MDA-MB-468 human breast carcinoma xenotransplanted mass (c,d) 48 hours after injection.
(a)
(b)
(c)
(d)